Sep 29, 2017 at Spandidos Publications

Lumican expression in gastric cancer and its association with biological behavior and prognosis

By : Spandidos Publications

A new study found an association between lumican expression and invasive potential in gastric cancer and may be an independent prognostic factor.

Read More
Sep 27, 2017 at Dovepress

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells

By : Dovepress

Researchers look into At-Rich Interactive Domain 1A (ARID1A), which is frequently mutated in gastric cancers with poor prognosis, finding AKT inhibition might be an effective treatment for ARID1A deficient cells.

Read More
Sep 26, 2017 at Science Direct

The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms

By : Science Direct

New research shows gut microbiota may affect chemotherapy efficacy and immunotherapy as well as impact post-surgery complications in gastric cancer patients.

Read More
Sep 20, 2017 at PLOS one

High PROX1 expression in gastric cancer predicts better survival

By : PLOS one

A recent study investigates PROX1 expression in gastric cancer, which is a transcription factor involved in various organ development. Researchers found high cytoplasmic PROX1 expression is an independent marker of better prognosis.

Read More
Sep 18, 2017 at ESMO

ESMO 2017 Press Release: Pembrolizumab: Promising Response Rate in Pretreated Metastatic Gastric Cancer


Breaking news was just released at the European Society for Medical Oncology Congress in Madrid: new data in phase two of the KEYNOTE-059 trial of Pembrolizumab (Keytruda) shows promising results in treating metastatic gastric cancer.

Read More